Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor mk 421 (enalapril) in captopril‐intolerant patients
Open Access
- 1 July 1984
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 27 (7) , 826-828
- https://doi.org/10.1002/art.1780270716
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Captopril and EnalaprilAnnals of Internal Medicine, 1983
- Variable response to oral angiotensin‐converting‐enzyme blockade in hypertensive scleroderma patientsArthritis & Rheumatism, 1982
- CaptoprilNew England Journal of Medicine, 1982
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981
- Clinical Course of Patients with Scleroderma Renal Crisis Treated with CaptoprilNephron, 1981
- The Captopril-Induced EruptionArchives of Dermatology, 1980
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979
- The management of renal sclerodermaThe American Journal of Medicine, 1978
- Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patientsJournal of Chronic Diseases, 1973